Literature DB >> 33224016

Intrauterine Growth Restriction and Hypertrophic Cardiomyopathy as Prenatal Ultrasound Findings in a Case of Leprechaunism.

Kevin Perge1,2, Mona Massoud3,4, Hélène Gauthier-Moulinier5, Olivier Lascols6, Nicolas Pangaud7, Carine Villanueva1,2, Linda Pons8.   

Abstract

Donohue syndrome (leprechaunism; OMIM *246200) is a rare and often lethal autosomal recessive disease caused by mutations in the INSR gene. We report the case of a 29-year-old pregnant woman, primigravida, who was referred at 33 weeks of gestation for severe intrauterine growth restriction (IUGR). Ultrasound examination found severe IUGR associated with an obstructive hypertrophic cardiomyopathy (HCM), confirmed postnatally. The newborn's blood glucose level fluctuated from fasting hypoglycemia to postprandial hyperglycemia. The infant was found to be homozygous for a novel missense pathogenic variant, c.632C>T (p.T211l), in exon 2 of the INSR gene, predicted to result in an abnormal insulin receptor. To our knowledge, this is the first report of leprechaunism being revealed by IUGR and HCM during the prenatal period. Clinicians should keep in mind that the association of these prenatal signs could indicate leprechaunism and specific early neonatal management could be proposed, in particular with recombinant human insulin-like growth factor-I.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Donohue syndrome; Hyperinsulinism; Hypertrophic cardiomyopathy; Insulin resistance; Intrauterine growth restriction; Leprechaunism

Year:  2020        PMID: 33224016      PMCID: PMC7675228          DOI: 10.1159/000509837

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  14 in total

1.  [Antenatal diagnosis of a recurrent case of leprechaunism].

Authors:  A Bouzid; A Ayachi; I Khammessi; I Chelli; M Mourali
Journal:  Gynecol Obstet Fertil       Date:  2015-06-10

2.  Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.

Authors:  J Nakae; M Kato; M Murashita; N Shinohara; T Tajima; K Fujieda
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

Review 3.  Clinical review 125: The insulin receptor and its cellular targets.

Authors:  Y Kido; J Nakae; D Accili
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

Review 4.  Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction.

Authors:  J Dupont; D LeRoith
Journal:  Horm Res       Date:  2001

Review 5.  Genetic syndromes of severe insulin resistance.

Authors:  Robert K Semple; David B Savage; Elaine K Cochran; Phillip Gorden; Stephen O'Rahilly
Journal:  Endocr Rev       Date:  2011-05-02       Impact factor: 19.871

Review 6.  Insulin signaling pathways and cardiac growth.

Authors:  Brian J DeBosch; Anthony J Muslin
Journal:  J Mol Cell Cardiol       Date:  2008-03-19       Impact factor: 5.000

7.  Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study.

Authors:  Michael D Pettersen; Wei Du; Mary Ellen Skeens; Richard A Humes
Journal:  J Am Soc Echocardiogr       Date:  2008-04-11       Impact factor: 5.251

Review 8.  IGF-I treatment of insulin resistance.

Authors:  Anna McDonald; Rachel M Williams; Fiona M Regan; Robert K Semple; David B Dunger
Journal:  Eur J Endocrinol       Date:  2007-08       Impact factor: 6.664

9.  Hypertrophic cardiomyopathy in Donohue syndrome.

Authors:  Jacqueline U M Termote; Johannes M P J Breur; Monique A M J de Vroede
Journal:  Cardiol Young       Date:  2015-11-11       Impact factor: 1.093

Review 10.  Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.

Authors:  Michaela Plamper; Bettina Gohlke; Felix Schreiner; Joachim Woelfle
Journal:  Int J Mol Sci       Date:  2018-04-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.